The News That Matters
Sildenafil (Viagra) treats erectile dysfunction in males. In the United States, two drugs have been approved to treat low libido in females. Some people call these medications “Viagra for females.”Viagra is the trade name of…
Plants have been used as the source of drugs for long ages, and as of today, approximately 70,000 species have been screened for their potential utility as medicines. In recent decades, several antitumor drugs have…
Incense harvesters in Indonesia’s North Sumatra province say the construction of a new center for research into medicinal plants threatens their livelihoods.The government says the center will boost Indonesia’s food and drug security, and maximizing…
Toronto, Ontario--(Newsfile Corp. - January 13, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as…
LAS VEGAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of Parkinson’s disease. Zhittya’s “Compassionate Use Clinical…
Issued on: 12/01/2022 - 14:11 The European Union drugs watchdog has voiced doubt over the need for a fourth Covid booster, saying the Omicron variant could help turn the coronavirus into an endemic disease that…
ProBio-Lite is a gut health supplement for men and women over eighteen. It is the best market supplement to defend and cure acid reflux and bowel syndromes of every grade. Official Website: Click Here What…
As superbugs become increasingly dangerous to human health, NC State researchers have developed a soft material that preserves medicines capable of treating infections without the risk of antimicrobial resistance. With his colleague Christopher Gorman in the…
Preferred Portfolio Partnership with Caris Will Streamline Development of HotSpot's Portfolio by Integrating Broad Tissue and Liquid Molecular Profiling, Artificial Intelligence Driven Mining of Large Datasets, and Clinical-Translational Innovations to Deliver Novel Allosteric Medicines to…
Anticipated 2022 milestones include initial clinical data for EDIT-301 in sickle cell disease by year-end, dosing of first TDT patient with EDIT-301, initiation of pediatric high-dose cohort for EDIT-101 in LCA10, and a clinical data…